Open J Gate, Genamik, Google Gelehrte, ISA (Indische wissenschaftliche Zusammenfassungen), CAS Datenbank (Chemische abstrakte Dienstleistungen), CABI (UK), Index Copernicus, Hinari, EBSCO, Ulrich's Periodicals Directory, Botanical Pesticides, Weed Abstracts, AgBiotechNet, VetMed Ressource , Abstracts zur Pflanzenphysiologie, Abstracts zur Agroforstwirtschaft, Abstracts zur Helminthologie, Ziergartenbau, Abstracts zu pflanzengenetischen Ressourcen, Nachrichten und Informationen zu Schweinen, Abstracts zur Milchwissenschaft, Datenbank für Agrarökonomie, Datenbank zur Parasitologie, CAB-Abstracts, Zoologische Aufzeichnungen, Nachrichten und Informationen nach der Ernte, Ernährungs- und Lebensmittelwissenschaften Datenbank, Organische Forschung Datenbank, Globale Gesundheit, ABC Chemie,Wissenschaftszentrale und SCIMAGO sind in der Bearbeitung vieler weiterer.
Barbara Teter, Katelyn S Kavak, Channa Kolb, Patricia K Coyle and Bianca Weinstock Guttman on behalf of the New York State Multiple Sclerosis Consortium
Background: Pregnancy in multiple sclerosis (MS) is marked by a decrease in relapse activity with a corresponding rebound in the first months postpartum. Becaus..Mehr sehen»
Ann Hemingway
This keynote paper will introduce the internat..Mehr sehen»
Sahmi O. Alhajri
This paper presents an incorporated methodology for evaluating the effect that circulated energy assets (DERs), including irregular photovoltaic (PV) age, may have on the unwave..Mehr sehen»
Gilbert Vera, Jason Rebecca
Immune checkpoint inhibitor immunotherapy has transformed the treatment of Non-Small Cell Lung Cancer (NSCLC). Although monoclonal antibodies against programmed cell death-1 (PD..Mehr sehen»
Ying-Chou Chen, Chi-Hua Ko, Wen-Chan Chiu, Fu-Mei Su and Jia-Feng Chen
Purpose: Comprehensive evaluation, including multiple recesses of all accessible peripheral joints, may be overly time-consuming in daily practice and in conduc..Mehr sehen»
Falkenstern-Ge RF, Kimmich M, Wohlleber M, Bode-Erdmann S, Friedel G, Ott G, and Kohlhäufl M
We The immune checkpoint modulator, nivolumab (BMS-936558/ONO-4538), is the first PD-1 inhibitor to gain regulatory approval, for the treatment of patients with unresectable mel..Mehr sehen»